This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
8/11/2020
Operator
Conference Call Operator
Good morning and welcome to the Fulcrum Therapeutics conference call. Currently, all participants are in a listen-only mode. There will be a question-and-answer session at the end of this call. I'd now like to turn the call over to Christy Warrick, Director of Investor Relations and Corporate Communications at Fulcrum. Please proceed.
Christy Warrick
Director of Investor Relations and Corporate Communications
Thank you, Anthony. Good morning, and thank you for joining us. Earlier today, we issued two press releases. One outlining the results of our interim analysis for Los Matamad and FSHD, and another outlining our recent corporate progress and financial results for the second quarter of 2020.
Dazeen Ahmad
Analyst, Bank of America
You can find both of these in the Investor Relations section of our website at locrumts.com.
You're reading a preview of the FULC Q2 2020 earnings call.
Free account.
Disclaimer